...
【24h】

Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia.

机译:神经调节蛋白-1基因在精神分裂症患者外周血中表达的探索性研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Neuregulin-1 (Nrg-1)(1) gene has been considered as a schizophrenia susceptibility gene. In order to observe the association of Nrg-1 gene with schizophrenia, the study was designed to investigate the effect of anti-psychotic treatment on the Nrg-1 mRNA expression in peripheral blood lymphocytes of the patients with a diagnosis of schizophrenia. The Nrg-1 mRNA expression in peripheral blood lymphocytes (PBLs) was measured by using semi-quantitative RT-PCR in 31 first-onset schizophrenia patients, 16 sibling controls and 31 no-sibship controls. Results showed that Nrg-1 mRNA expression in PBLs of patients was lower than that in other two control groups (F=6.722, P=0.002). However, as follow-up time extended, from the second week, Nrg-1 mRNA expression of PBLs in antipsychotic treated patients gradually increased and has obvious statistical significance compared the efficacy of taking anti-psychotic before and after therapy. These results demonstrated that Nrg-1 gene has association with schizophrenia. It is possible to select Nrg-1 mRNA expression of PBLs in schizophrenia patients as a potential therapeutic marker.
机译:Neuregulin-1(Nrg-1)(1)基因被认为是精神分裂症的易感基因。为了观察Nrg-1基因与精神分裂症的相关性,本研究旨在研究抗精神病治疗对诊断为精神分裂症的患者外周血淋巴细胞Nrg-1 mRNA表达的影响。使用半定量RT-PCR检测31例初发精神分裂症患者,16例同胞对照和31例无陪伴对照的外周血淋巴细胞(PBL)中Nrg-1 mRNA的表达。结果显示,患者PBLs中Nrg-1 mRNA的表达低于其他两个对照组(F = 6.722,P = 0.002)。然而,随着随访时间的延长,从第二周开始,抗精神病药物治疗患者中PBLs的Nrg-1 mRNA表达逐渐增加,与治疗前后服用抗精神病药物的疗效相比具有明显的统计学意义。这些结果证明Nrg-1基因与精神分裂症有关。可以选择精神分裂症患者中PBL的Nrg-1 mRNA表达作为潜在的治疗标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号